Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case–control study
✍ Scribed by S Wilailak; C Vipupinyo; V Suraseranivong; K Chotivanich; C Kietpeerakool; Y Tanapat; S Therasakvichya; S Hamontri; V Linasmita; S Bunyapipat; S Chindavijak; K Ittiwisavakul; N Khemapech; P Suekwattana; D Thanapprapasr; P Lumbiganon
- Book ID
- 115270593
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 83 KB
- Volume
- 119
- Category
- Article
- ISSN
- 1470-0328
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Publication of t h e International Union Against Cancer Publication de I'Union lnternationale Contre le Cancer DEPOT-MEDROXYPROGESTERONE ACETATE (DMPA) AND RISK OF ENDOMETRIAL CANCER THE WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES The data collection centers, and the principal in
## Abstract A hospital‐based case‐control study was conducted to assess the possible relationship between use of depot‐medroxy‐progesterone acetate (DMPA), an injectable progestational contraceptive, and the development of liver cancer in 2 developing countries where hepatitis B is endemic. Informa
Supom KOETSAWANG (PI), Duangdao RACHAWAT (CI), Orawan KIRIWAT (CI), Amorn KOETSAWANC (P).